MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-HR-13-0000311
Adley Formulations Private Limited - pharma in Panchkula, Haryana, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹85.86 Cr
▲ 47% YoY
Net profit · FY 2024
₹7.64 Cr
Net margin 8.9%
EBITDA · FY 2024
₹14.46 Cr
EBITDA margin 16.8%
Authorised capital
₹1.3 Cr
Registered with MCA
Paid-up capital
₹1.26 Cr
Issued & subscribed
Open charges
₹19.85 Cr
Satisfied ₹11.39 Cr
Company age
8 yrs
Est. 2018
Employees · EPFO
193
Provident fund records
About Adley Formulations Private Limited
Data last updated:
Adley Formulations Private Limited is a private limited company based in Panchkula, Haryana, India, a subsidiary of Beta Drugs Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 09 October 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24303HR2018PTC076347. Its GSTIN is 02AARCA4431F1Z0 (Himachal Pradesh). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹1.3 Cr and a paid-up capital of ₹1.26 Cr. It is led by directors including Rahul Batra (Whole-Time Director) and Varun Batra (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Cabin No. 1 Ist Floor SCO – 184 Sector – 5, Panchkula, Haryana, India – 134114.
As per the financials filed for FY 2024, the company reported a revenue of ₹85.86 Cr, a growth of 47% compared to the previous year. For the same year it recorded a net profit of ₹7.64 Cr (net margin 8.9%) and EBITDA of ₹14.46 Cr (EBITDA margin 16.8%). Revenue has grown at a compounded annual rate (CAGR) of 39% over three years and 61% over five years.
The company has about 193 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Beta Drugs. As per MCA filings, the company has open charges of ₹19.85 Cr and satisfied charges of ₹11.39 Cr on record. Court records list 10 cases involving the company, including 6 filed by the company and 4 filed against it; 5 cases are pending. The company has 1 deal on record (1 rights issue); the latest was in February 2019. The company has 12 MSME Form 1 returns on record between 2019 and 2023, listing 735 overdue payments to 37 micro and small suppliers.
Adley Formulations Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-HR-13-0000311). For more details, the company can be reached via its website adleyformulations.tradeindia.com.
Company details
CIN U24303HR2018PTC076347
Registration Number 076347
Incorporation Date 09 October 2018
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Parent Company Beta Drugs Limited
MSME Classification Medium
Udyam Registration UDYAM-HR-13-0000311
Key People
Rahul Batra Whole-Time Director Varun Batra Whole-Time Director Ram Chandra Jha Whole-Time Director Recognitions & Rankings of Adley Formulations
Contact details
Adley Formulations Private Limited's registered office is in Panchkula, Haryana. Its website is adleyformulations.tradeindia.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressCabin No. 1 Ist Floor SCO – 184 Sector – 5, Panchkula, Haryana, India – 134114
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Adley Formulations Private Limited, buy the company report.
Comprehensive company report
Adley Formulations Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Adley Formulations operates one associated brand: Beta Drugs. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Developer of therapeutics for oncology and dermatology | betadrugslimited.com |
Financials of Adley Formulations Private Limited
FY 2025 filings availableAdley Formulations Private Limited reported revenue of ₹85.86 Cr (up 47% YoY) for FY 2024.
Revenue · FY 2024
₹85.86 Cr ▲ 47%
Net profit · FY 2024
₹7.64 Cr margin 8.9%
EBITDA · FY 2024
₹14.46 Cr margin 16.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 47%
3 years · compounded
▲ 39%
5 years · compounded
▲ 61%
EBITDA CAGR growth
1 year
▲ 16%
3 years · compounded
▲ 37%
5 years · compounded
▲ 57%
Revenue has grown at a compounded annual rate (CAGR) of 61% over five years, including 47% growth in the latest year. EBITDA rose 16% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹85.86 Cr | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹14.46 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹7.64 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 16.8% | ||||
| Net Profit Margin | 8.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Adley Formulations Private Limited, buy the company report.
Board of directors of Adley Formulations Private Limited
Adley Formulations has 4 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rahul Batra | Whole-Time Director | 09 Oct 2018 | 8 Years 0 Months | Current |
| Varun Batra | Whole-Time Director | 09 Oct 2018 | 8 Years 0 Months | Current |
| Ram Chandra Jha | Whole-Time Director | 09 Oct 2018 | 8 Years 0 Months | Current |
| Monica Jain Also directs: Beta Drugs Limited | Additional Director | 03 Sep 2025 | 1 Years 1 Months | Current |
Auditor
Adley Formulations Private Limited is audited by KALRA RAI & ASSOCIATES for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| KALRA RAI & ASSOCIATES | FY 2024 | 008859N |
Shareholding
The shareholding of Adley Formulations Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Adley Formulations Private Limited, buy the company report.
Charges & borrowings
Open charges
₹19.85 Cr
Satisfied charges
₹11.39 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 02 Sep 2025 | 101157165 | Others | ₹50 Lakh | Open | |
| 04 Mar 2025 | 101059946 | Axis Bank Limited | ₹1.98 Cr | Open | |
| 11 Oct 2024 | 100991666 | Others | ₹23.8 Lakh | Open | |
| 04 Nov 2023 | 100812149 | Hdfc Bank Limited | ₹20 Lakh | Open | |
| 27 Jul 2023 | 100761774 | Others | ₹9 Lakh | Open |
To see the full charge records of Adley Formulations Private Limited, buy the company report.
Total charge records: 14 View all charges
Deals & funding
Adley Formulations Private Limited has 1 deal on record (1 rights issue); the latest was in February 2019.
Total deals
1
Rights issue
1
Deals on record (1 of 1)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Feb 2019 | Rights issue | ₹1.25 Cr | Investors: Beta Drugs Limited |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Adley Formulations Private Limited has 10 court cases on record: 6 filed by Adley Formulations, 4 filed against it. 5 cases are pending and 5 are disposed.
Total cases
10
Filed by the company
6
Filed against the company
4
Pending
5
Disposed
5
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 8 | 4 | 3 |
| District courts | 2 | 0 | 2 |
Cases on record (5 of 10)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Panchkula, Haryana | Civil suit | Filed by the company against M/S Aaltramed Health Care Limited | Pending |
| District court, Panchkula, Haryana | Civil suit | Filed by the company against M/S Shafina Medical Store and 1 other | Pending |
| High Court of Himachal Pradesh | Appeal | Filed against the company by State of Himachal Pradesh Through Its Chief Secretary Room No E 201B Secretriat Shimla HP Pin 171002 | Pending |
| High Court of Himachal Pradesh | Interim or miscellaneous application | Filed against the company by State of Himachal Pradesh Through Its Chief Secretary Room No E 201B Secretriat Shimla HP Pin 171002 | Pending |
| High Court | Court case (CMP.M) | Filed against the company by State of Himachal Pradesh Through Its Chief Secretary Room No E 201B Secretriat Shimla HP Pin 171002(Not Applicable) Ag | Disposed |
To see the full case history of Adley Formulations Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Adley Formulations Private Limited has 12 MSME Form 1 returns on record between 2019 and 2023, listing 735 overdue payments to 37 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 37)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Aps Imperia Private Limited | |||
| Adley Lab Limited | |||
| Arihant Labels | |||
| Amit Print N Pack | |||
| BBN Foils |
To see the full MSME payment records of Adley Formulations Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Adley Formulations Private Limited has a workforce of 193 employees on its EPFO records as of Apr 05, 2024, across 1 active EPFO establishment.
Employee count
193
Active EPFO establishments
1
Employee growth
38.85%
GST
Adley Formulations has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 02AARCA4431F1Z0 | Himachal Pradesh | Active | 15 Dec 2018 |
| 30AARCA4431F1Z1 | Goa | Active | 23 Jan 2025 |
To see the full GST registrations and return filing status of Adley Formulations Private Limited, buy the company report.
Recent activity
Adley Formulations Private Limited has 10 board changes on record since 2018: 5 appointments and 5 cessations. The latest: Monica Jain was appointed as Additional Director on 03 Sep 2025.
AGM
Adley Formulations Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Appointed
Monica Jain was appointed as Additional Director.
Charges
A charge with Others amounted to Rs. 0.50 Cr with Charge ID 101157165 was registered on 02 Sep 2025.
Charges
A charge registered on 01 Oct 2020 via Charge ID 100397046 with Hdfc Bank Limited was fully satisfied on 20 Aug 2025.
Charges
A charge with Others of Rs. 15.36 Cr registered on 27 Jan 2020 with Charge ID 100325900 was modified on 31 May 2025.
Charges
A charge registered on 05 Apr 2021 via Charge ID 100434653 with Hdfc Bank Limited was fully satisfied on 07 Apr 2025.
Filing
Adley Formulations Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Charges
A charge with Axis Bank Limited amounted to Rs. 1.98 Cr with Charge ID 101059946 was registered on 04 Mar 2025.
Charges
A charge with Others amounted to Rs. 0.24 Cr with Charge ID 100991666 was registered on 11 Oct 2024.
Charges
A charge registered on 24 Aug 2020 via Charge ID 100366126 with Others was fully satisfied on 16 Jan 2024.
Charges
A charge registered on 25 Jan 2020 via Charge ID 100331050 with Others was fully satisfied on 24 Nov 2023.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.20 Cr with Charge ID 100812149 was registered on 04 Nov 2023.
21 earlier events are in the company report.
Frequently asked questions
Adley Formulations is an active private limited company based in Panchkula, Haryana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 09 October 2018 (8+ years old) and is registered under CIN U24303HR2018PTC076347.
Adley Formulations has 4 current directors:
- Rahul Batra - Whole-Time Director
- Varun Batra - Whole-Time Director
- Ram Chandra Jha - Whole-Time Director
- Monica Jain - Additional Director
The latest financial statements of Adley Formulations on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Adley Formulations is 02AARCA4431F1Z0, registered in Himachal Pradesh. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 30AARCA4431F1Z1 (Goa).
The CIN (Corporate Identification Number) of Adley Formulations is U24303HR2018PTC076347. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Adley Formulations has 10 court cases on record: 6 filed by the company and 4 filed against it. 5 are pending. Most are in the high courts.
Adley Formulations was incorporated on 09 October 2018, making it 8+ years old. It is registered with the Registrar of Companies, Delhi.
Adley Formulations has 1 deal on record (1 rights issue); the latest was in February 2019.
Monica Jain was appointed as Additional Director on 03 Sep 2025. Nipun Arora was appointed as CFO on 08 May 2023. Rahul Batra ceased to be Director on 01 Apr 2021. Adley Formulations has 10 board changes on record in total.
Yes, Adley Formulations is registered as a medium enterprise under Udyam registration (number: UDYAM-HR-13-0000311).
Adley Formulations has 12 MSME Form 1 returns on record between 2019 and 2023, listing 735 overdue payments to 37 micro and small suppliers. The latest return was filed on 31 Jan 2024.